LOS ANGELES CAPITAL MANAGEMENT LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$436,764
-16.1%
404,411
+0.2%
0.00%0.0%
Q2 2023$520,471
+1.3%
403,466
+3.7%
0.00%0.0%
Q1 2023$513,654
-14.7%
389,132
-3.1%
0.00%
-33.3%
Q4 2022$602,384
+80.9%
401,589
+42.3%
0.00%
+50.0%
Q3 2022$333,000
+20.7%
282,239
+15.5%
0.00%
+100.0%
Q2 2022$276,000
-63.3%
244,429
-2.8%
0.00%
-66.7%
Q1 2022$752,000
+12.7%
251,5290.0%0.00%
+50.0%
Q4 2021$667,000
-26.9%
251,5290.0%0.00%
-50.0%
Q3 2021$913,000
-23.5%
251,529
-8.6%
0.00%
-20.0%
Q2 2021$1,194,000
+21.5%
275,109
-4.3%
0.01%
+25.0%
Q1 2021$983,000
-66.1%
287,499
-65.3%
0.00%
-66.7%
Q4 2020$2,896,000
+28.2%
827,421
-12.1%
0.01%
+20.0%
Q3 2020$2,259,000
+31.2%
941,392
+0.0%
0.01%
+25.0%
Q2 2020$1,722,000
+102.4%
941,050
+72.5%
0.01%
+60.0%
Q1 2020$851,000
+55.0%
545,684
+112.8%
0.01%
+66.7%
Q4 2019$549,000
+66.9%
256,410
+45.8%
0.00%
+50.0%
Q3 2019$329,000
-28.3%
175,8950.0%0.00%0.0%
Q2 2019$459,000
+1.5%
175,8950.0%0.00%
-33.3%
Q1 2019$452,000
+11.6%
175,8950.0%0.00%0.0%
Q4 2018$405,000
-35.2%
175,895
-9.7%
0.00%0.0%
Q3 2018$625,000
+78.1%
194,830
+57.2%
0.00%
+50.0%
Q2 2018$351,000
-43.9%
123,930
-23.2%
0.00%
-71.4%
Q1 2014$626,000161,3100.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders